BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2410614)

  • 1. Comparison of the cellular cytotoxic activities of colostral lymphocytes and maternal peripheral blood lymphocytes.
    Nair MP; Schwartz SA; Slade HB; Johnson MZ; Quebbeman JF; Beer AE
    J Reprod Immunol; 1985 May; 7(3):199-213. PubMed ID: 2410614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates.
    Nair MP; Schwartz SA; Menon M
    Cell Immunol; 1985 Aug; 94(1):159-71. PubMed ID: 3926326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of decreased T-cell-mediated natural cytotoxicity and interferon production in Down's syndrome.
    Nair MP; Schwartz SA
    Clin Immunol Immunopathol; 1984 Dec; 33(3):412-24. PubMed ID: 6209046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay.
    Bradley TP; Bonavida B
    Cell Immunol; 1984 Jan; 83(1):199-207. PubMed ID: 6420079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.
    Nair MP; Lewis EW; Schwartz SA
    J Clin Immunol; 1986 Sep; 6(5):363-72. PubMed ID: 2429979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities.
    Fukui H; Overton WR; Herberman RB; Reynolds CW
    J Leukoc Biol; 1987 Feb; 41(2):130-42. PubMed ID: 2433376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sensitivity of placental trophoblast cells to intraplacental and allogeneic cytotoxic lymphocytes.
    Pross H; Mitchell H; Werkmeister J
    Am J Reprod Immunol Microbiol; 1985 May; 8(1):1-9. PubMed ID: 4014527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood lymphocytes from thermal injury patients are defective in their ability to generate lymphokine-activated killer (LAK) cell activity.
    Klimpel GR; Herndon DH; Stein MD
    J Clin Immunol; 1988 Jan; 8(1):14-22. PubMed ID: 2966807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
    Rolstad B; Fossum S
    Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
    J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells.
    Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
    Transplantation; 1991 Feb; 51(2):451-9. PubMed ID: 1994542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers.
    Nair MP; Laing TJ; Schwartz SA
    Clin Immunol Immunopathol; 1986 Jan; 38(1):68-78. PubMed ID: 3484438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells.
    Radrizzani M; Gambacorti-Passerini C; Parmiani G; Fossati G
    Cancer Immunol Immunother; 1989; 28(1):67-73. PubMed ID: 2462469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
    Nair MP; Schwartz SA
    J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
    Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
    J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
    Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
    J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.